首页> 美国卫生研究院文献>Interventional Neuroradiology >Experimental testing of the dual-layer Woven EndoBridge device using an elastase-induced aneurysm model in rabbits
【2h】

Experimental testing of the dual-layer Woven EndoBridge device using an elastase-induced aneurysm model in rabbits

机译:使用弹性蛋白酶诱导的动脉瘤模型在兔体内进行双层Woven EndoBridge装置的实验测试

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The dual-layer Woven EndoBridge (WEB) device (WEB II) is designed to improve the performance of the first-generation WEB device. This study was performed to evaluate the acute and chronic performance of WEB II for aneurysm occlusion in an elastase-induced aneurysm model in rabbits. We implanted WEB II devices in 36 elastase-induced aneurysms and followed up for one, three, six, and 12 months. Degree of aneurysm occlusion at follow-up was graded on the Web Occlusion Scale (WOS): Grade A, complete aneurysm occlusion; Grade B, complete occlusion with recess filling; Grade C, residual neck filling; and Grade D, residual aneurysm filling. Hematoxylin and eosin staining was performed for histological assessment of aneurysm healing. Grades A, B, C, and D aneurysm occlusion at one-month follow-up were noted in three (17%), three (17%), eight (44%), and four (22%) of 18 cases, respectively. At the three-month time point Grades A, B, C, and D were shown in two (33%), two (33%), one (17%), and one (17%) aneurysms. Six months after treatment, one (17%), two (33%), two (33%), and one (17%) cases demonstrated Grades A, B, C, and D occlusion. At the 12-month time point, Grades B, C, and D were shown in three (50%), two (33%), and one (17%) aneurysms. Histologic evaluation showed progressive thrombus organization within aneurysm lumen from one to 12 months. These results indicated that the WEB II device can achieve high rates of aneurysm occlusion over time in experimental aneurysms.
机译:双层Woven EndoBridge(WEB)设备(WEB II)旨在提高第一代WEB设备的性能。进行这项研究以评估在弹性蛋白酶诱导的兔动脉瘤模型中WEB II对动脉瘤阻塞的急慢性表现。我们将WEB II装置植入了36个由弹性蛋白酶诱发的动脉瘤中,并进行了1、3、6和12个月的随访。随访时的动脉瘤闭塞程度根据Web闭塞量表(WOS)进行分级:A级,完全动脉瘤闭塞; B级,完全闭塞,有凹陷填充; C级,残留颈部充盈; D级,残余动脉瘤充盈。进行苏木精和曙红染色以对动脉瘤愈合进行组织学评估。在18个月的病例中,分别在三个月(17%),三个(17%),八个(44%)和四个(22%)记录到A,B,C和D级动脉瘤闭塞情况。 。在三个月的时间点,分别在两个(33%),两个(33%),一个(17%)和一个(17%)动脉瘤中显示出A,B,C和D级。治疗六个月后,分别有1例(17%),2例(33%),2例(33%)和1例(17%)表现为A,B,C和D级闭塞。在12个月的时间点,B,C和D级分别显示为3个(50%),2个(33%)和1个(17%)动脉瘤。组织学评估显示在动脉瘤腔内进行性血栓形成从1到12个月。这些结果表明,随着时间的推移,WEB II设备在实验性动脉瘤中可以实现较高的动脉瘤闭塞率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号